The ability to determine the functional capacity of putative human hematopoietic stem cell (HSC) populations requires in vivo assays in which long-term multilineage differentiation can be assessed. We hypothesized that if human fetal bone was transplanted adjacent to a fetal thymus fragment in severe combined immunodeficient (SCID) mice, a conjoint organ might form in which HSC in the human bone marrow (BM) would mimic human multilineage differentiation into progenitor cells, B cells, and myeloid cells; undergo self-renewal; and migrate to and differentiate into T cells within the thymic microenvironment. To test this possibility, SCID mice were transplanted subcutaneously with HLA class I mismatched fetal bone, thymus, and spleen fragments (SCID-hu BTS). We found that the BM of SCID-hu BTS grafts maintained B cells, myeloid cells, CD34+ cells for at least 36 weeks posttransplant. Assayable hematopoietic progenitors colony-forming units-granulocyte- macrophage were present in 100% (66/66) of grafts over a period of 28 weeks. Cells with a HSC phenotype (CD34+Thy-1+Lin-) were maintained for 20 weeks in SCID-hu BTS grafts. These CD34+Thy-1+Lin- cells had potent secondary multilineage reconstituting potential when isolated and injected into a secondary HLA mismatched SCID-hu bone assay and analyzed 8 weeks later. In addition, early progenitors within the BM of SCID-hu BTS grafts were capable of migrating to the human thymus and undergoing differentiation through immature CD4+CD8+ double-positive T cells and produce mature T cells with a CD4+CD8- or CD8+CD4- phenotype that could be detected for at least 36 weeks. Phenotypically defined human fetal liver (FL) and umbilical cord blood (UCB) hematopoietic stem cell populations were injected into irradiated SCID-hu BTS grafts to assess their multilineage repopulating capacity and to assess the ability of the BTS system to provide an environment where multiple lineages might differentiate from a common stem cell pool. Injection of irradiated grafts with FL HSC or UCB HSC cells resulted in donor- derived B cells, myeloid cells, immature and mature T cells, and CD34+ cells in individual grafts when analyzed 8 weeks postreconstitution, further showing the multipotential nature of these stem cell populations. In addition, a strong correlation was observed between maintenance of host graft-derived CD8+ cells and failure of donor stem cell engraftment.(ABSTRACT TRUNCATED AT 400 WORDS)
Skip Nav Destination
ARTICLES|
September 1, 1995
Human allogeneic stem cell maintenance and differentiation in a long- term multilineage SCID-hu graft
CC Fraser,
CC Fraser
Experimental Cell Therapy Group, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
H Kaneshima,
H Kaneshima
Experimental Cell Therapy Group, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
G Hansteen,
G Hansteen
Experimental Cell Therapy Group, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
M Kilpatrick,
M Kilpatrick
Experimental Cell Therapy Group, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
R Hoffman,
R Hoffman
Experimental Cell Therapy Group, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
BP Chen
BP Chen
Experimental Cell Therapy Group, SyStemix Inc, Palo Alto, CA 94304, USA.
Search for other works by this author on:
Blood (1995) 86 (5): 1680–1693.
Citation
CC Fraser, H Kaneshima, G Hansteen, M Kilpatrick, R Hoffman, BP Chen; Human allogeneic stem cell maintenance and differentiation in a long- term multilineage SCID-hu graft. Blood 1995; 86 (5): 1680–1693. doi: https://doi.org/10.1182/blood.V86.5.1680.bloodjournal8651680
Download citation file:
September 1 1995
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal